|
BAG-3/BIS (BAG3)
|
NM_004281 |
BCL2-associated athanogene 3 |
up 8.2 |
|
BCL-B/Boo (BCL2L10)
|
NM_020396 |
BCL2-like 10 (apoptosis facilitator) |
up 29.4 |
|
BIP1/BP4 (BIK)
|
NM_001197 |
BCL2-interacting killer (apoptosis-inducing) |
up 9.9 |
|
AIP1/API2 (BIRC3)
|
NM_001165 |
Baculoviral IAP repeat-containing 3 |
up 10.4 |
|
ILP-2/ILP2 (BIRC8)
|
NM_033341 |
Baculoviral IAP repeat-containing 8 |
up 8.0 |
|
ALPS2/FLICE2 (CASP10)
|
NM_001230 |
Caspase 10, apoptosis-related cysteine peptidase |
up 16.8 |
|
MGC119078 (CASP14)
|
NM_012114 |
Caspase 14, apoptosis-related cysteine peptidase |
up 45.5 |
|
Bp50/CDW40 (CD40)
|
NM_001250 |
CD40 molecule, TNF receptor superfamily member 5 |
up 95.1 |
|
CD154/CD40L (CD40LG)
|
NM_000074 |
CD40 ligand (TNF superfamily, member 5, hyper-IgM syndrome) |
up 52.2 |
|
CIDE-A (CIDEA)
|
NM_001279 |
Cell death-inducing DFFA-like effector a |
up 27.3 |
|
APT1LG1/CD178 (FASLG)
|
NM_000639 |
Fas ligand (TNF superfamily, member 6) |
up 33.3 |
|
DP5/HARAKIRI (HRK)
|
NM_003806 |
Harakiri, BCL2 interacting protein (contains only BH3 domain) |
up 66.6 |
|
LT/TNFB (LTA)
|
NM_000595 |
Lymphotoxin alpha (TNF superfamily, member 1) |
up 110.6 |
|
ASC/CARD5 (PYCARD)
|
NM_013258 |
PYD and CARD domain containing |
up 6.3 |
|
DIF/TNF-alpha (TNF)
|
NM_000594 |
Tumor necrosis factor (TNF superfamily, member 2) |
up 703.4 |
|
APO2/CD261 (TNFRSF10A)
|
NM_003844 |
Tumor necrosis factor receptor superfamily, member 10a |
up 22.8 |
|
S152/T14 (CD27)
|
NM_001242 |
CD27 molecule |
up 8.1 |
|
4–1BB/CD137 (TNFRSF9)
|
NM_001561 |
Tumor necrosis factor receptor superfamily, member 9 |
up 302.6 |
|
CD27L/CD27LG (CD70)
|
NM_001252 |
CD70 molecule |
up 38.2 |
|
CD153/CD30L (TNFSF8)
|
NM_001244 |
Tumor necrosis factor (ligand) superfamily, member 8 |
up 22.3 |
